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Background and aims: Chronic cough is a common symptom the aetiology of which can be challenging to
diagnose. Diagnostic protocols for chronic cough have required the use of specialist investigations which are not
always easily available. We wanted to determine whether patients with chronic cough can be successfully managed
using a clinical algorithm.
Methods: 112 consecutive patients with chronic cough were prospectively recruited into this study. They were
assessed by history, physical examination, chest radiograph, spirometry and reversibility to nebulised salbutamol. A
clinical diagnosis was made and the patient had an 8-week trial of appropriate therapy. Further therapeutic trials
were carried out depending on response to treatment and the possible differential diagnoses. Investigations were
carried out in cases of failed clinical trials and to exclude specific pathology. The “clinical arm” comprised patients
managed on the basis of clinical assessment and without any investigations. The “investigative arm” comprised
those who needed further investigations.
Results: 81 (72%) were managed in the clinical arm. Of these 74 (66%) were discharged following response to
therapy. 31 (28%) patients were converted to the investigative arm after failure of diagnosis in the clinical protocol.
The commonest causes of cough were gastroesophageal reflux, asthma and chronic rhinitis. 51 (45.5%) patients
responded to therapy based on diagnosis at initial assessment while a further 23 (20.5%) patients responded to
sequential clinical trials for the commonest causes of cough. Cough severity score improved by a mean of 3.6
points on a numeric response score (from 0–10, p < 0.0001).
Conclusion: It is possible to manage a majority of chronic cough patients successfully using a protocol based on
presenting symptoms and therapeutic trials for the common causes of cough.
Keywords: Cough, Differential diagnosis, Diagnostic techniques and proceduresIntroduction
Chronic cough has been arbitrarily defined as a cough
lasting more than 8 weeks [1]. The distinction between
acute and chronic cough is important as the epidemi-
ology and the aetiology of these differ. Chronic cough is
a very common symptom with which patients present to
both primary and secondary care [2,3]. A diagnostic ap-
proach involving the systematic use of specialist investi-
gations to elucidate the underlying cause of the cough
has been advocated [4]. Whilst this approach has been* Correspondence: sfaruqi@doctors.net.uk
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reproduction in any medium, provided the orshown to result in successful diagnosis and treatment of
a majority of chronic cough patients, it does require the
routine use of investigations which may be uncomfort-
able for the patient and which may not be easily access-
ible to physicians in primary or secondary care [4,5].
Many studies from around the world have repeatedly
confirmed that the commonest causes of chronic cough
are gastro-oesophageal reflux (GOR), asthma and related
syndromes and upper airways disease (post nasal drip
syndrome, rhinitis and sinusitis) [6-8]. These diagnoses
accounted for up to 93% of chronic cough in these stud-
ies. It is our experience that these conditions present
with differentiated symptoms, which suggests that itd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and examination.
Based on this premise we hypothesised that in a large
proportion of patients with chronic cough the diagnosis
can be made simply based on history, examination and
simple tests that are commonly available and treatment
of the underlying condition can be instituted in a timely
fashion without undertaking expensive investigations. In
cases where the diagnosis is not clear from initial assess-
ment, sequential trial of therapy for the three common-
est conditions should cause resolution of symptoms in a
significant proportion of patients.
To test these hypotheses we designed a clinical proto-
col for the management of cough based on the history,
examination, chest radiograph and spirometry tests,
which would be available to all clinicians seeing patients
with chronic cough. A protocol based on clinical assess-
ment and routinely available simple tests would be par-
ticularly useful in primary care.
Methods
Subjects
Sequential consenting adult patients (112 patients, above
18 years of age) of either sex referred on both a secondary
and tertiary basis to the Hull Cough Clinic with a history
of chronic cough were prospectively enrolled into the
study over a period of 18 months. Patients who had been
on angiotensin converting enzyme (ACE) inhibitors had
the therapy stopped at least one month prior to the clinic
appointment. This is because ACE inhibitors cause a sig-
nificant increase in the sensitivity of the cough reflex [9].
Thus, symptomatic cough due to any cause will be exacer-
bated by the concomitant use of an ACE inhibitor.
Assessment
1. Clinical protocol1.1 A detailed history and examination was carried
out by one of the physicians (Cough Clinic
Proforma, Additional file 1). The examination
included complete general physical and systemic
examinations.
1.2 Plain postero-anterior chest radiograph was
performed in all patients at the time of the first
visit to clinic. The film was assessed initially by
the physician in clinic, but a formal report from a
radiologist was also routinely obtained. This is a
recommendation endorsed by all current
guidelines in order to exclude serious lung
pathology as a cause [1,5,10].
1.3 Lung function tests (spirometry and reversibility
testing) were performed using a Vitalograph
compact spirometer (Vitalograph LtdW,Buckingham, UK) in order to screen for any
significant airways disease. Parameters measured
were forced expiratory flow volume in 1 second
(FEV1) and forced vital capacity (FVC). The
patient performed three forced expiratory
manoeuvres from total lung capacity to residual
volume and the best of the three was used in the
analysis. To assess reversibility, we measured the
percentage change in FEV1 20 minutes after the
administration of 2.5 mg of nebulised salbutamol
(Ventolin NebulesW Allen and Hanburys Ltd,
Middlesex, UK) over 5 minutes using an oxygen
driven venturi mask.
1.4 The physician used this information to make a list
of differential diagnoses and the patient was
managed as outlined in Figure 1. Features
considered to support the diagnosis of asthma
were associated wheeze, breathlessness and an
obstructive pattern or reversibility on spirometry.
Presence of dyspeptic symptoms was considered
to support a diagnosis of reflux related cough. A
history of post nasal mucus drip and / or
recurrent throat clearing would be supportive of a
diagnosis of upper airways disease. The above
were considered as general guides to diagnosis
which was based on the overall assessment of the
individual clinician. An 8-week trial of therapy for
the main diagnosis was carried out after which
the patient was reviewed for response. If there
had been no improvement then either treatment
for the initially made diagnosis was further
escalated or empirical treatment for the next
likely cause of cough was instituted. If history and
examination suggested more than one cause of
cough and there was partial improvement of the
cough, treatments for the other likely causes were
added serially to that of the first. In patients in
whom no clear diagnosis could be made at the
initial assessment empirical sequential therapeutic
trials (STT) were carried out for the three
commonest causes of cough, each over a period
of 8 weeks. Treatment recommendations were
along the lines of the British Thoracic Society
guidelines [1]. When therapeutic trials failed,
investigations were carried out as per the
investigational protocol described below.
Investigations were also carried out when initial
screening had suggested specific lung pathology.
2. Investigational protocol
Patients who failed to respond to treatment in the
clinical protocol were managed by an investigational
protocol similar to that used by most secondary
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Figure 1 Management pathway for the clinical protocol. Figure legend: Initial empirical treatment for reflux related cough was acid
suppressive therapy (lansoprazole 30 mg bd with ranitidine 300 mg on). If this did not lead to amelioration of symptoms and airway reflux was
thought to be the cause, sequentially pro-kinetics (metoclopramide 10 mg tds / domperidone 10 mg tds) and baclofen (5 mg tds and increased
to 10 mg tds depending upon response / tolerance) trials were instituted prior to transfer to sequential trials or the investigational protocol. The
initial treatment for asthma and related disorders was with a high dose inhaled cortico-steroid and long acting beta2 agonist combination
inhaler. Subsequent additional therapy was with montelukast (10 mg od). The treatment for rhinitis was with an inhaled nasal cortico-steroid with
the addition of anti-histamine as additional therapy.
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on clinical suspicion. These include sputum cytology
studies, bronchial provocation testing, sinus x-rays
and computerised tomography (CT), chest CT,
upper gastrointestinal studies (gastroesophagoscopy,
oesophageal manometry and 24 hr pH monitoring)
and fibreoptic bronchoscopy.
3. Study endpoint
Successful response to treatment was taken as
confirmation of diagnosis and the study endpoint. It
was defined as treatment for the given diagnosis
resulting in either cessation of cough or significant
reduction in cough to a point that it no longer
disturbed the patient. This was based on patients self
reported subjective response.
Analysis of data
Data analysis was performed using SPSS version 10.0 (SPSS
Inc; Chicago, IL, USA). Data for patient characteristicswere expressed as mean (±SD). Relationship between
symptoms and diagnosis was analysed using Fisher’s Exact
t-test with level of significance taken as p = 0.05. The sensi-
tivity and specificity of symptoms in directing diagnosis
was compared in patients in whom treatment was success-
ful based on initial assessment to those who either needed
STT or investigations for diagnosis. Data was analysed on
an intention to treat basis.
Ethical approval
Ethical approval for this study was granted by the Hull
and East Riding Local Research Ethics Committee.
Results
One hundred and twelve (73 female, mean age 56.2
years) patients were recruited into this study. Table 1
summarises the main characteristics of patients at the
time of enrolment in the study. Eighty one patients were
managed in the clinical arm. Of these, 74 (66%) were
Table 1 Patient characteristics at the time of referral
Total number of patients (number female) 112 (73)
Mean age 56.2 years
Median duration of cough (range) 3 years (0.25-64 years)
Smoking history:
Current smokers 6 (5%)
Ex-smokers 46 (41%)
Never smoked 60 (54%)
Sputum production:
No sputum 45 (40%)
Clear sputum 43 (38%)
Purulent sputum 23 (21%)
Cough preceded by URTI 35 (31%)
Symptoms associated with cough:
Wheeze 46 (41%)
Breathlessness 60 (54%)
Acid taste in mouth 26 (23%)
Heartburn 48 (43%)
PND 40 (36%)
Throat clearing 73 (65%)
URTI = upper respiratory tract infection, PND = post-nasal drip. Cough duration
did not have a normal distribution.
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and 7 were lost to follow up. Thirty one (27.7%) patients
were converted to the investigational protocol after fail-
ure of response to treatment in the clinical protocol. In
18 of these a diagnosis was made, 8 remain undiagnosed
and 5 were lost to follow-up.
Clinical protocol results
In 51 (45.5%) patients, therapy based on the differential
diagnosis at initial assessment led to resolution or sig-
nificant reduction of symptoms, while 23 (20.5%) patientsTable 2 Diagnoses of patients at discharge
Diagnosis Clinical Assessment Sequential The
n = 51 n =
Frequency (%) Frequen
Reflux related cough 19 (37.3) 2 (8
Asthma 17 (33.3) 2 (8
Rhinitis 5 (9.8) 3 (1
Post-infective 4 (7.8) 0
Multiple Causes 3 (5.8) 8 (34
Idiopathic 0 0
Other * 3 (5.8) 8 (34
The clinical assessment arm includes those who responded to treatment for the ini
arm comprised those responded to treatment given for an alternate diagnosis, hav
protocol arm comprised those failed to respond to sequential therapeutic trials and
infective cough was made on the basis of a history to suggest a preceding respirat
diagnoses included bronchiectasis, cancer, interstitial lung disease and self-limitingresponded to STT. Reflux related cough and asthma
comprised more than two thirds of the initial diagnoses
considered. Therapy prescribed is as per Figure 1. On
STT a majority of patients responded to treatment for the
second diagnosis instituted as part of the STT. The com-
monest single cause of cough was reflux related cough.
The triad of reflux related cough, asthma and chronic
rhinitis comprised the vast majority (Table 2). Mean dur-
ation of follow-up for those in the clinical protocol was
16.9 (±10.8) weeks. Mean subjective cough severity as
recorded on the numeric response score (Additional file 1)
improved from 6.3 (±2.5) to 2.7 (±2.8) (p < 0.0001).
Two patients had chest x-rays suggestive of lung can-
cer and appropriate investigations confirmed this. Chest
CT scans were also performed in the patients with bron-
chiectasis and interstitial lung disease as part of the
management process.
History and basic investigations
In the 51 patients in whom successful treatment was
based on the initial assessment, symptoms associated
with diagnosis of reflux associated cough were heartburn
and sour taste in the mouth (p ≤ 0.01). A diagnosis of
asthma was associated with a history of wheeze and dys-
pnoea (p ≤ 0.01). Rhinitis was significantly associated
with postnasal drip (p = 0.002). The amount and type of
phlegm did not contribute to the diagnosis. Examination
findings were helpful in patients with bronchiectasis and
interstitial lung disease. Reversibility was highly specific
but poorly sensitive for the diagnosis of asthma. Chest
radiograph was contributory in 7 (6.3%) patients. The
sensitivity and specificity of various symptoms related to
final outcomes are shown in Table 3.
Discussion
Our results indicate that it is possible to successfully
manage a majority of patients with chronic cough basedrapeutic Trials Conventional Protocol Total
23 n = 18 n = 92
cy (%) Frequency (%) Frequency (%)
.7) 6 (33.3) 27 (29.3)
.7) 1 (5.6) 20 (21.7)
3) 3 (11.7) 11 (12)
0 4 (4.3)
.7) 0 11 (12)
7 (38.9) 7 (7.6)
.7) 1 (5.6) 12 (13)
tial diagnosis made at the first clinic review. The sequential therapeutic trials
ing failed therapy for the initial diagnosis considered. The investigational
needed specific investigations to establish a diagnosis. A diagnosis of post
ory tract infection and the cough having improved at the clinic review. Other*
cough.






Asthma Wheeze 94 66 <0.001




Reversibility 11 95 0.2
Reflux Acid taste 50 80 0.01
Heartburn 72 68 0.001
Rhinitis Post nasal mucus
drip
100 67 0.002
Throat clearing 100 37 0.07
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study had all been seen previously by at least one phys-
ician and included tertiary referrals. A combination of
treatment of the likely diagnoses and sequential thera-
peutic trials for the commonest causes of cough led to
resolution of symptoms in two-thirds of our patients.
This in fact compares favourably with other studies that
have used an investigational approach in management of
cough patients [4,12,13]. Our results suggest that it would
be possible to successfully manage a significant proportion
of patients with chronic cough without the need for spe-
cialist referral or investigations. This is a management ap-
proach which is both effective and cost saving.
A previous study looking into managing patients using
an approach of a sequence of trial-and-error treatments
based on a presumptive hierarchy of possible diagnoses
has shown that this is a feasible option [14]. In this study
chronic cough was defined as that lasting more than 4
weeks and a trial of treatment of a week was much
shorter than in our study. The commonest cause for
chronic cough, based on response to treatment, was
found to be post nasal drip syndrome. Previous epi-
demiological studies have shown wide variation in spe-
cific aetiologies of chronic cough [7,8]. In this study a
response rate of over 90% was demonstrated although
arguably in view of the definition of chronic cough used,
in a proportion of patients their cough may have been
self limited. The results of both our study and this re-
port support this approach to managing patients with
chronic cough.
Since this study was performed in a specialist cough
clinic, one might question whether the sample is repre-
sentative of the general practice population. Although
we know that cough is a common problem in primary
care, there are few studies in the literature looking at the
causes of chronic cough in this setting. Patient selection
may be a problem, but in practice, the fundamental diffi-
culty is how to confirm a diagnosis. This study’sprincipal aim was to test the efficacy of a diagnostic
protocol, which could be used in general practice, rather
than to describe the frequency of causes of chronic
cough. Since approximately 75% of the patients in our
sample were referred from primary care, this group
should represent patients which General Practitioners
find difficult to diagnose and for whom use of a clinical
diagnostic protocol would be beneficial.
Confirmation of diagnosis was based on successful
therapeutic trial. The most common diagnosis was GOR
related chronic cough. It is well known that there is a
large placebo response seen in the treatment of chronic
cough. It has been shown the response in cough to acid
suppression with proton pump inhibitors is no better
than placebo [15,16]. Presence of dyspeptic symptoms
was a marker of positive response seen in this study,
which is what we have observed in our randomised trial
as well [15]. Unlike the classical symptoms of GOR dis-
ease where the result of gastric acid exposure lead to
mucosal damage and symptoms, non-acid or even gas-
eous reflux is thought to play a major role in reflux
associated cough. Acid suppressive therapy leads to a de-
crease in gastric acid secretion but does not lead to im-
provement in reflux events themselves as these are
mainly related to transient lower oesophageal sphincter
relaxation (TLOSR) [17,18]. Further escalation for treat-
ment for reflux used in our clinic includes a trial of pro-
kinetics (metoclopramide and domperidone) and drugs
which reduce TLOSR (baclofen). Baclofen is known to
attenuate pharmacologically induced cough as well
[19,20]. Although we do not have data from well orga-
nised clinical trials to support the above, an empirical
trial is justified from our understanding of reflux related
cough. Although commonly used for other indications,
all the above medications do have their associated adverse
effects. Metoclopramide, Domperidone and Baclofen are
all associated with CNS side effects. The very commonly
used proton pump inhibitors also have associated side
effects which include an increased risk of developing
pneumonia [15]. The benefits of a trial of therapy have to
be balanced against the possible adverse effects. All our
patients had chronic debilitating cough and empirical trial
of treatment was discussed with them prior to initiation
of therapy.
Antihistamines may have activity on a number of tus-
sive mechanisms [21]. Central reduction of cough thresh-
old may be associated with sedative activity, whereas
blockade of mast cell derived histamine may be an effect-
ive treatment of rhinitis or asthma [22,23]. Antihistamines
may also work on attenuating the cough reflex itself by an
effect on the transient receptor potential ion channels
[24]. Because of this lack of specificity a precise diagnosis
cannot necessarily be relied on in this study. We suggest
that the response to therapy experienced by patients was
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of previous treatment and the long duration of cough.
We assessed response to therapy based on subjective
report of the patient and a graduated numeric response
scale. Cough-specific quality-of-life scales have been vali-
dated in the assessment of chronic cough. Other de-
scriptive scores or visual analogue scales have not been
validated. We have shown that various forms of subject-
ive assessment of cough are reproducible at 8 weeks and
correlate well with both objective cough counting as well
as cough-specific quality-of-life questionnaire scores [25].
Hence although the scale used by us in this study cannot
reflect scores on other subjective means of assessment,
such as the visual analogue scale, it would be appropriate
to subjectively quantify the severity of cough.
As in other studies two thirds of our patients were fe-
male. GOR was more common amongst our patients
while fewer had rhinitis as compared to previous studies
[6,7]. All patients had previously been tried on some
form of therapy and it was only when these did not suc-
ceed that they were referred to the cough clinic. This
may well have altered the mix of patients we saw com-
pared with the general population. Studies have shown
that chronic cough is slow to resolve on therapy and this
may explain why therapeutic trials of less than eight weeks
have limited success [4,26]. In a significant proportion of
patients no underlying diagnosis was established despite a
sequential trials of treatment and extensive investigations.
This is the experience of other centres as well. Recently
the “cough hypersensitivity syndrome” has been proposed
as a unifying diagnosis for patients with chronic cough
which may explain the pathogenesis of cough in this
group of patients [27]. Our group of patients did not have
another clinic review once they had reported improve-
ment in their cough. Hence long term follow up data is
not available and is a limitation of this study.
It is of interest to note that although 31% of patients
gave a history of an upper respiratory tract infection pre-
ceding the onset of the cough only 4% had a diagnosis of
post-infective cough at discharge. In general, respiratory
tract infections cause acute cough more commonly than
chronic cough, but prolonged post viral cough does occur.
This often resolves spontaneously and therefore may have
been selected out of our study population in the time be-
tween referral and attendance at clinic. However, since
viruses seem to cause cough by lowering the threshold of
the cough reflex, [28,29] it is not uncommon in our ex-
perience to see patients in whom an upper respiratory
tract infection seems to unmask a cough which is due to a
different cause but was previously sub-clinical.
In contrast to previous studies which did not find in-
formation on the character, timing and complications of
cough useful in identifying the underlying cause, [30] we
have shown that important diagnostic information iscontained in the presenting complex of symptoms which
are usually associated with the common causes of cough.
For instance dyspeptic symptoms, if present, would sug-
gest a diagnosis of reflux related cough. However quite
often dyspeptic symptoms are absent in patients with re-
flux related cough. Other symptoms which would point
to this diagnosis include: cough on phonation, on rising
from bed, associated with certain foods or with eating in
general [31]. There is considerable overlap of associated
symptoms which patients with chronic cough have, how-
ever based on the presentation a correct diagnosis can
be established in a large proportion. We think that air-
way reflux leading to an enhanced cough reflex is the
most common cause of chronic cough and we have
termed this the cough hypersensitivity syndrome. The
validated Hull Airway Reflux Questionnaire is a useful
tool to diagnose this [27].
Conclusion
In this study we have demonstrated that it is possible to
manage a majority of chronic cough patients successfully
using a clinically based protocol without the need of in-
tensive investigations. Therapeutic trials must be of ad-
equate duration to be successful. The presenting complex
of symptoms was indicative of the underlying cause of
cough highlighting the importance of history taking in the
assessment of patients. Chest x-rays, despite their low
sensitivity, are a useful tool in screening for parenchymal
lung pathology. Spirometric results are specific but do not
significantly contribute to the diagnosis of cough predom-
inant asthma.
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